These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 9690923)

  • 1. Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Girona J; Masana L
    Atherosclerosis; 1998 Jun; 138(2):383-9. PubMed ID: 9690923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.
    Aouizerat BE; Allayee H; Cantor RM; Dallinga-Thie GM; Lanning CD; de Bruin TW; Lusis AJ; Rotter JI
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2730-6. PubMed ID: 10559018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of high density lipoprotein composition to plasma lecithin:cholesterol acyltransferase concentration in men.
    Miller NE; Rajput-Williams J; Nanjee MN; Samuel L; Albers JJ
    Atherosclerosis; 1988 Feb; 69(2-3):123-9. PubMed ID: 3126747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II.
    Jones RJ; Owens D; Brennan C; Collins PB; Johnson AH; Tomkin GH
    Atherosclerosis; 1996 Jan; 119(2):151-7. PubMed ID: 8808492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lecithin:cholesterol acyltransferase activity and high-density lipoprotein subfraction composition in type 1 diabetic patients with improving metabolic control.
    Weight MJ; Coetzee HS; Smuts CM; Marais MP; Maritz JS; Hough FS; Benadé AJ; Taljaard JJ
    Acta Diabetol; 1993; 30(3):159-65. PubMed ID: 8111077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DNA polymorphism for LCAT is associated with altered LCAT activity and high density lipoprotein size distributions in baboons.
    Rainwater DL; Blangero J; Hixson JE; Birnbaum S; Mott GE; VandeBerg JL
    Arterioscler Thromb; 1992 Jun; 12(6):682-90. PubMed ID: 1350465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of serum amyloid A on cholesterol esterification in human plasma.
    Steinmetz A; Hocke G; Saïle R; Puchois P; Fruchart JC
    Biochim Biophys Acta; 1989 Nov; 1006(2):173-8. PubMed ID: 2512983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the interaction of lecithin: cholesterol acyltransferase with subfractions of high density lipoproteins.
    Jahani M; Lacko AG
    J Lipid Res; 1981 Sep; 22(7):1102-10. PubMed ID: 7299290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity of HDL subfractions towards lecithin-cholesterol acyltransferase. Modulation by their content in free cholesterol.
    Simard G; Loiseau D; Girault A; Perret B
    Biochim Biophys Acta; 1989 Oct; 1005(3):245-52. PubMed ID: 2804054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-heparin plasma lipoprotein and hepatic lipases. Relationships to high density lipoprotein cholesterol and to apolipoprotein CII in familial hyperalphalipoproteinemic and in normal subjects.
    Taskinen MR; Glueck CJ; Kashyap ML; Srivastava LS; Hynd BA; Perisutti G; Robinson K; Kinnunen PJ; Kuusi T
    Atherosclerosis; 1980 Oct; 37(2):247-56. PubMed ID: 7426098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes.
    Fournier N; Atger V; Paul JP; de la Llera Moya M; Rothblat G; Moatti N
    Atherosclerosis; 1999 Dec; 147(2):227-35. PubMed ID: 10559507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel LCAT mutation (Phe382-->Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100.
    Nanjee MN; Stocks J; Cooke CJ; Molhuizen HO; Marcovina S; Crook D; Kastelein JP; Miller NE
    Atherosclerosis; 2003 Sep; 170(1):105-13. PubMed ID: 12957688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the cholesterol content of reconstituted LpA-I on lecithin:cholesterol acyltransferase activity.
    Sparks DL; Anantharamaiah GM; Segrest JP; Phillips MC
    J Biol Chem; 1995 Mar; 270(10):5151-7. PubMed ID: 7890624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of lipolytic enzymes and high-density lipoprotein subfractions induced by physical activity in type 2 diabetes mellitus.
    Lehmann R; Engler H; Honegger R; Riesen W; Spinas GA
    Eur J Clin Invest; 2001 Jan; 31(1):37-44. PubMed ID: 11168437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia.
    Calabresi L; Villa B; Canavesi M; Sirtori CR; James RW; Bernini F; Franceschini G
    Metabolism; 2004 Feb; 53(2):153-8. PubMed ID: 14767865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.
    Albers JJ; Chen CH; Adolphson JL
    J Lipid Res; 1981 Nov; 22(8):1206-13. PubMed ID: 7320631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
    Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between apo A-I-containing lipoproteins and lecithin:cholesterol acyltransferase.
    Ikeda Y; Ohta T; Matsuda I
    Biochim Biophys Acta; 1994 Dec; 1215(3):307-13. PubMed ID: 7811716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.